medigraphic.com
ISSN 1561-3054 (Electronic)

2012, Number 3

<< Back Next >>

Rev Cubana Med Trop 2012; 64 (3)

Susceptibility of Aedes aegypti (L.) strains from Havana to a Bacillus thuringiensis var. israelensis

Menéndez DZ, Rodríguez RJ, Gato AR, Companioni IA, Díaz PM, Bruzón ARY

Language: Spanish
References: 17
Page: 324-329
PDF size: 47.23 Kb.


ABSTRACT

Introduction: the integration of chemical and biological methods is one of the strategies for the vector control, due to the existing environmental problems and the concerns of the community as a result of the synthetic organic insecticide actions. The bacterium called Bacillus thuringiensis var. israelensis in liquid formulation has been widely used in the vector control programs in several countries and has shown high efficacy at lab in Cuba.
Objective: to determine the susceptibility of Aedes aegypti collected in the municipalities of La Habana province to Bacillus thuringiensis var. israelensis.
Methods: fifteen Aedes aegypti strains, one from each municipality, were used including larvae and pupas collected in 2010 and one reference strain known as Rockefeller. The aqueous formulation of Bacillus thuringiensis var. israelensis (Bactivec, Labiofam, Cuba) was used. The bioassays complied with the World Health Organization guidelines for use of bacterial larvicides in the public health sector. The larval mortality was read after 24 hours and the results were processed by the statistical system SPSS (11.0) through Probit analysis.
Results: the evaluated mosquito strains showed high susceptibility to biolarvicide, there were no significant differences in LC50 values of Ae. aegypti strains, neither in the comparison of these values with those of the reference strain.
Conclusions: the presented results indicate that the use of Bacillus thuringiensis var. israelensis continues to be a choice for the control of Aedes aegypti larval populations in La Habana province.


REFERENCES

  1. Boisvert M. Utilization of Bacillus thuringiensis var. israelensis (Bti) - Based Formulations for the Biological Control of Mosquitoes in Canada. Victoria BC, Coté JC, Otvos IS, Schwartz JL, Vincent C, editors. 6th Pacific Rim Conference on the Biotechnology of Bacillus thuringiensis and its Environmental Impact; 2005.

  2. World Health Organization Global strategic framework for integrated vector management Geneva: WHO; 2004. (WHO/CDS/CPE/2004.10)

  3. World Health Organization. Dengue Guidelines for diagnosis, treatment, prevention and control. Geneva: WHO; 2009. (WHO/HTM/NTD/DEN/2009.1)

  4. Bisset JA, Rodríguez MM, Hernández M, Ricardo Y, Montada D, Gato R, et al. Efectividad de formulaciones de insecticidas para el control de adultos de Aedes aegypti en La Habana, Cuba. Rev Cubana Med Trop. 2011;63(2):166-70.

  5. Bisset JA, Rodríguez MM, Fernández D, Pérez O. Estado de la resistencia a insecticidas y mecanismos de resistencia en larvas del municipio Playa, colectadas durante la etapa intensiva contra el Aedes aegypti en Ciudad de La Habana, 2001-2002. Rev Cubana Med Trop. 2004;56(1):61-6.

  6. Rodriguez MM, Bisset JA, Fernandez D. Levels of insecticide resistance and resistance mechanisms in Aedes aegypti from some Latin American countries. J Am Mosq Control Assoc. 2007;23(4):420-9.

  7. Becker N. Microbial control of mosquitoes vectors. 1st Asian Congress of Parasitology and Tropical Medicine & 40 th Annual Scientific Seminar of MSPTM. Symposium 10: Bti/Bsp, March 2004; p. 80.

  8. Gato R, Díaz M, Bruzón R, González A, Hernández Y, García I. Estudio de resistencia de Aedes aegypti a Bacillus thuringiensis var. israelensis. Rev Cubana Med Trop. 2008;60(1):74-7.

  9. Armada, JA, Trigo JA. Metodología de encuestas. Campaña Anti-aegypti. La Habana: Ministerio de Salud Pública, Cuba; 1981.

  10. Pérez O, Rodríguez J, Bisset JA, Leyva M, Díaz M, Fuentes O, et al. Manual de indicaciones técnicas para insectarios. La Habana: Editorial Ciencias Médicas; 2004.

  11. World Health Organization. Guideline specifications for bacterial larvicides for public health use. Geneva: WHO; 1999. (WHO/CDS/CPC/WHOPES/99.2)

  12. Loke SR, Andy-Tan WA, Benjamin S, Lee HL, Sofian-Azirun M. Susceptibility of field-collected Aedes aegypti (L.) (Diptera: Culicidae) to Bacillus thuringiensis israelensis and temefos. Trop Biomed. 2010;27(3):493-503.

  13. Becker N, Ludwing M. Investigation on possible resistance in Aedes vexans field populations after a 10-year application of Bacillus thuringiensis israelensis. J Am Mosq Control Assoc. 1993;9:221-4.

  14. Setha T, Chantha N, Socheat D. Efficacy of Bacillus thuringiensis israelensis, VectoBac® WG and DT, formulations against dengue mosquito vectors in cement potable water jars in Cambodia. Southeast Asian J Trop Med Pub Health. 2007;38:261-8.

  15. Lacey LA. Bacillus thuringiensis serovariety israelensis and Bacillus sphaericus for mosquito control. J Am Mosq Control Assoc. 2007;23(2 Suppl):133-63.

  16. Paul A, Harrington LC, Zhang L, Scott JG. Insecticides resistance in Culex pipiens from New York. J Am Mosq Control Assoc. 2005;21(3):305-9.

  17. Masuh H, Seccacini E, De Licastro S, Zerba E. Residualidad de un formulado sólido del insecticida microbiano Bti (H-14) en el control de larvas de Aedes aegypti (Diptera: Culicidae). Rev Peruana Epidemiol. 2002;10(7). Disponible en: http://sisbib.unmsm.edu.pe/bvrevistas/epidemiologia/v10_n7/residualidad_insecticida.htm




2020     |     www.medigraphic.com